Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji,, Chuo-ku, Tokyo, 104-0045, Japan.
The Japanese Breast Cancer Society Clinical Practice Guidelines for Systemic Treatment of Breast Cancer Panel Membership, Tokyo, Japan.
Breast Cancer. 2020 May;27(3):322-331. doi: 10.1007/s12282-020-01085-0. Epub 2020 Apr 2.
We present the English version of The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
The JBCS formed a task force to update the JBCS Clinical Practice Guidelines, 2015 edition, according to Minds Handbook for Clinical Practice Guideline Development 2014. First, we set multiple outcomes for each clinical question (CQ). Next, quantitative or qualitative systematic review was conducted for each of the multiple outcomes, and the strength of recommendation for the CQ was taken into consideration during meetings, with the aim of finding a balance between benefit and harm. Finalized recommendations from each session were confirmed through discussion and voting at the recommendation decision meeting.
The recommendations, the strength of recommendation and the strength of evidence were determined based on systemic literature reviews and the meta-analyses for each CQ.
The JBCS updated the Clinical Practice Guidelines for systemic treatment of breast cancer.
我们呈现了日本乳腺癌学会(JBCS)2018 年版乳腺癌系统治疗临床实践指南的英文版。
JBCS 成立了一个工作组,根据 2014 年 Minds 临床实践指南制定手册更新了 JBCS 2015 年版临床实践指南。首先,我们为每个临床问题(CQ)设定了多个结局。接下来,对每个多个结局进行了定量或定性的系统评价,并在会议中考虑了对 CQ 的推荐强度,旨在在获益和危害之间找到平衡。通过推荐决策会议上的讨论和投票,对每个会议的最终建议进行了确认。
根据对每个 CQ 的系统文献回顾和荟萃分析,确定了推荐意见、推荐强度和证据强度。
JBCS 更新了乳腺癌系统治疗的临床实践指南。